Podcasts about Imaging

Welcome to Season 2 of the Orthobullets Podcast.In this episode, we review the high-yield topic of Knee Imaging ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Knee & Sports section.⁠Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube

Over the centuries, we have learned to peer into what was once invisible. Imaging devices like cameras, telescopes, microscopes, and MRI machines map the world around, beyond, and within us in ways the naked eye could never see. In so doing, these technologies have transformed our understanding of our place in the universe and our conception of our own bodies--and we may be on the cusp of an even greater revolution. Daniel K. Sodickson--a physicist and biomedical imaging innovator--explores the rich history and surprising future of vision, from the evolution of eyes to emerging high-tech devices. Beginning in the early oceans, when organisms first developed sight, The Future of Seeing: How Imaging is Changing the World (Columbia UP, 2025) tells the stories of the many remarkable tools people have invented to extend our natural vision. Ranging from the tales of brilliant inventors to profiles of everyday people, this book shows how imaging has transformed the practice of medicine, reshaped the global economy, and complicated the notion of privacy. In the era of artificial intelligence, Sodickson argues, it will be reinvented even further, emulating not only our senses but also our brains. Inviting and eye-opening, The Future of Seeing is a revelatory look at what imaging teaches us about the way we see the world, each other, and ourselves. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

From cassoimaging.com - As one of the leading local businesses in the Norman area, we attribute our reputation to the lasting customer relationships we've developed throughout the years. We believe that all of our customers deserve the highest level of service, and we are committed to providing just that. Explore the rest of our site to learn more about what we have to offer, and get in touch with any questions. Casso Land & Imaging Services LLC is here for you. Here For You Casso Land & Imaging Services can offer full service imaging at a competitive rate with high production results. With our experienced crew of imagers, we are able to take on almost any task. Casso Land & Imaging Services would like to offer our courthouse expertise as a viable option for your business. We are in the courthouse - so you don't have to be. Satisfaction Guaranteed We would like to discuss how Casso Land & Imaging Services can personally tailor our work to your specific needs. Our entire crew can also obtain probates, wills and virtually any other document search that is needed for your organization. We have hands-on oversight on all projects to ensure timely and accurate high quality results. Please let us know how we can be of service to your business. Next Level Service We want all of our customers to experience the impressive level of professionalism when working with Casso Land & Imaging Services LLC. All of our services, especially this one, exist to make your life easier and stress free. You can trust us to supply you with the best products, as well as top quality customer service. Not Just Courthouse Document Imaging We specialize in courthouse document imaging but have grown to include historical document archiving and other business-essential document digitization. Our wide array of clients has allowed us to continue to deliver top-notch document imaging paired with advancing our technology to bring the best quality of work to you, at the quickest speed. GET IN TOUCH Casso Land & Imaging Services LLC is committed to exceeding your needs. Questions, comments or special requests? We'd love to hear from you, so don't hesitate to reach out today. scott@cassoimaging.com (405) 401-3590 scott.casso@gmail.com Address 401 W Tonhawa St, Norman, OK 73069, USA Cassoimaging.com

In today's rapidly changing world there are threats, natural disasters and environmental changes that can occur without notice that can negatively impact business and government operations. Delivering persistent, high-resolution insights anytime and anywhere using remote sensing is critical. Listen to this episode to better understand the powerful capabilities of high-resolution SAR imaging.

In this groundbreaking episode, we dive deep into MOJO Health's "Data Iceberg" concept that's revolutionizing cancer care. Many people make life-changing medical decisions using only 2 types of data - biopsy results and imaging scans. If you go to the most advanced cancer centers, you likely use 6, but there are 7 additional categories of health data hiding beneath the surface that will transform your healing strategy.What You'll Discover:- Why most healthcare operates on "tip of the iceberg" data- The 13 hidden data categories that predict treatment success- How molecular DNA profiling creates personalized treatment roadmaps- The power of circulating tumor DNA (liquid biopsies) for real-time monitoringPerfect for: Cancer patients, survivors, caregivers, healthcare advocates, and anyone who wants to transform from reactive to proactive healthcare.Remember: Data G's don't just hope their treatment is working. They know.Resources Mentioned:For our downloadable Guide to Be a Data G, please go to mojohealth.org/datagguideTo set up an appointment with Oscar Sierra, please reach out to https://www.sierracollaborativemed.com/To see National Cancer Institute's page the blood biomarkers: https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-listAnd here for information on different types of data to request: https://www.mojohealth.org/be-a-data-g-1Other Podcasts to watch:#4 A Data G's Guide to Beating Cancer w/ Julie Stevens and Oscar Sierra, L.Ac.#6 BRCA2 Data Dilemma: Lessons in Gene Expression#8 How Genomic Testing Can Transform Your Cancer JourneyWhat tests do you need your doctor to order? Biopsy, Imaging, Circulating Tumor DNA, and Molecular DNA of the Tumor.Basically everything else you can order on your own through Direct Patient Labs: https://www.mojohealth.org/direct-labs-mojo-panelsConnect with Julie Stevens and the MOJO Movement: Instagram: https://instagram.com/mojohealthorg TikTok: https://tiktok.com/@julie.stevens97YouTube: https://www.youtube.com/@mojohealth Facebook: https://facebook.com/mojohealthorg Website: https://www.mojohealth.org/DISCLAIMER: The views, thoughts, and opinions expressed on this podcast are the speaker's own and do not represent the views, thoughts, and opinions of MOJO Health Cooperative LLC, a Georgia Limited Liability Company, its respective officers, directors, employees, agents, or representatives. This podcast is presented by MOJO Health Cooperative, and cannot be copied or rebroadcast without consent. The material and information presented here is for general information purposes only, and not intended to supplant the expert advice and/or consultation of a medical doctor and/or a licensed physician, and/or an attorney. In short, this podcast is not intended to replace professional medical advice, nor legal advice. The "MOJO Health" name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of or opposition to any specific organization, product, or service. Again, none of the content of this podcast should be considered legal advice, nor medical advice. As always, consult a lawyer and/or a licensed physician in lieu of relying upon the advice of any of the participants of this podcast. The host(s) of this podcast are not licensed lawyers, physicians, doctors of osteopath, nor medical doctors in any jurisdiction anywhere. The host(s) of this podcast do not practice medicine and do NOT profess to be able to do any of the following: (1) diagnose, heal, treat, prevent, prescribe for, or removing any physical, mental, or emotional ailment or supposed ailment of an individual; (2) engage in the end of human pregnancy; (3) treat human ailments; nor (4) perform acupuncture. MOJO Health Cooperative LLC is not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.

Full article: Contrast-Enhanced Voiding Urosonography and Radionuclide Cystography for Diagnosing Vesicoureteral Reflux Using VCUG as the Reference Standard: Systematic Review and Meta-Analysis What is the current role of contrast-enhanced voiding urosonography in the detection of pediatric vesicoureteral reflux (VUR)? Raisa Amiruddin, MBBS, is joined by Hansel Otero, MD, to discuss the recent meta-analysis by Hayatghaibi et al. comparing imaging tests for VUR diagnosis.

In this episode, Alan is joined by visual artist Shefa Salem al‑Baraesi, a Benghazi‑based creator whose oil paintings re‑imagine Libya's archaeological heritage—like the inverted‑figure boat scene from the Acacus cave art—and ancient rituals such as the Kaska dance. Through her realistic, large‑scale works, Shefa transforms written history and myth into evocative visual narratives that resonate with everyday Libyans. Her exhibitions, I Am Libya and Ethnolibya, bring these ancestral images forward as a living, shared national memory.TranscriptsFor a rough transcript head over to: https://www.archaeologypodcastnetwork.com/rockart/151LinksArtist - shefa salemEXHIBITIONS - shefa salemArtists Exploring Libya's History, Cultural Resilience and RebirthShefa Salem: a Libyan artist, inspired by the history of her country‘All my work is Libya': Five emerging Libyan artists to watchContactDr. Alan Garfinkelavram1952@yahoo.comDr. Alan Garfinkel's WebsiteSupport Dr. Garfinkel on PatreonArchPodNetAPN Website: https://www.archpodnet.comAPN on Facebook: https://www.facebook.com/archpodnetAPN on Twitter: https://www.twitter.com/archpodnetAPN on Instagram: https://www.instagram.com/archpodnetAPN ShopAffiliates and SponsorsMotion Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Alan is joined by visual artist Shefa Salem al‑Baraesi, a Benghazi‑based creator whose oil paintings re‑imagine Libya's archaeological heritage—like the inverted‑figure boat scene from the Acacus cave art—and ancient rituals such as the Kaska dance. Through her realistic, large‑scale works, Shefa transforms written history and myth into evocative visual narratives that resonate with everyday Libyans. Her exhibitions, I Am Libya and Ethnolibya, bring these ancestral images forward as a living, shared national memory.TranscriptsFor a rough transcript head over to: https://www.archaeologypodcastnetwork.com/rockart/151LinksArtist - shefa salemEXHIBITIONS - shefa salemArtists Exploring Libya's History, Cultural Resilience and RebirthShefa Salem: a Libyan artist, inspired by the history of her country‘All my work is Libya': Five emerging Libyan artists to watchContactDr. Alan Garfinkelavram1952@yahoo.comDr. Alan Garfinkel's WebsiteSupport Dr. Garfinkel on PatreonArchPodNetAPN Website: https://www.archpodnet.comAPN on Facebook: https://www.facebook.com/archpodnetAPN on Twitter: https://www.twitter.com/archpodnetAPN on Instagram: https://www.instagram.com/archpodnetAPN ShopAffiliates and SponsorsMotion Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As the war in Gaza approaches its two year mark, criticism of Israel and support for the Palestinian population has ignited debates over free speech in the United States. Universities have become nexuses of protest against US support of Israel in the conflict, and the federal government's response has been to block education funding for schools and targeting activists for deportation. State governments and universities have begun taking their own actions to curtail pro-Palestine sentiments on campus. Nico Berlin has the story.Across Oklahoma, and the country, women are facing unaffordable childcare, rising maternal mortality rates, and a lack of support systems. National problems require national solutions, and Mom Congress, a 501(c)(3) charitable organization, is lobbying for federal legislation to address these gaps. Here's Danielle A. Melton.In May of this year, Oklahoma passed Senate Bill 806, otherwise known as the Food as Medicine Act. The bill aims to expand nutrition services and recognize the importance of food as a contributing factor to public health. A national organization based in Tulsa has been working to empower chefs to be nutrition leaders for their communities. Juddie Williams has details.In our first segment about music and social movements, Francia Allen explored how gospel, blues, and songs of the Civil Rights movement helped elevate the voices of resistance for African Americans. In part two of the series, she focuses on the powerful ways Indigenous communities have raised their voices in resistance and pushed back against cultural discrimination, immigration issues, and treaty violations while staying connected to Native traditions. Here's FBO's Francia Allen.The international conference Black Portraiture[s] will be hosted by New York University-Tulsa Friday October 3rd. The tenth in the series, the event will bring together scholars and artists to study the art and culture of the African Diaspora. Dr. Deborah Willis, University Professor and Chair of the Department of Photography & Imaging at the Tisch School of the Arts at New York University has been a co-organizer since 2006. For more information and registration online visit blackportraitures.infoTurns out finding you're allergic to coconut after eating half your birthday cake isn't the best party favor. For 11-year-old Sondra Slade, what started as the perfect day of pancakes, bike rides, and backyard BBQ ended with a dramatic faceplant into the condiment table – and a family still convinced that “just wiping it off” fixes everything. Focus: Black Oklahoma is produced in partnership with KOSU Radio & Tri-City Collective. Additional support is provided by the Commemoration Fund & Press Forward. Our theme music is by Moffett Music. Focus: Black Oklahoma's executive producers are Quraysh Ali Lansana & Bracken Klar. Our associate producers are Smriti Iyengar, Jesse Ulrich, & Naomi Agnew.Our production interns are Alexander Evans, Jess Grimes, Roma Carter, and Anna Wilson. You can visit us online at KOSU.org or FocusBlackOklahoma.com & on YouTube @TriCityCollectiveOK. You can follow us on Instagram @FocusBlackOK & on Facebook at Facebook.com/FocusBlackOK. You can hear Focus: Black Oklahoma on demand at KOSU.org, the NPR app, NPR.org, or wherever you get your podcasts.

Welcome to The Peptide Podcast. In this episode, we're unpacking the latest on retatrutide and how it measures up against semaglutide and tirzepatide.  If you want to support what we do, head over to our Partners Page. You'll find some amazing brands we trust—and by checking them out, you're helping us keep the podcast going.  https://pepties.com/partners/ We'll look closely at what the studies tell us so far — from overall weight loss to reductions in visceral fat and how much lean muscle mass is preserved. We'll also talk about where the evidence is solid, where it's still developing, and why cross-trial comparisons should be made with caution. What is retatrutide? So let's start with the basics—what is retatrutide? Retatrutide is a new type of weight-loss medication called a triple agonist. That sounds fancy, but what it really means is that it targets three hormone receptors in the gut and pancreas: GLP-1, GIP, and glucagon. Each of these plays a slightly different role in metabolism and appetite regulation. To break it down: GLP-1, which you might already know from drugs like semaglutide, mainly slows digestion, helps you feel full, and improves insulin sensitivity. GIP, which tirzepatide targets along with GLP-1, also helps regulate blood sugar and may improve how the body stores and burns fat. Retatrutide adds glucagon receptor activation on top of that, which seems to further boost fat burning. So how does this compare to semaglutide and tirzepatide? Semaglutide is a GLP-1-only drug, so it mainly works by reducing appetite and slowing gastric emptying. Tirzepatide is a dual agonist, hitting GLP-1 and GIP, which gives it a slightly stronger effect on blood sugar control and fat metabolism compared to semaglutide. Retatrutide goes one step further by adding glucagon activity, potentially giving more total fat loss. In other words, you can think of it like a spectrum: semaglutide hits one target, tirzepatide hits two, and retatrutide hits three—each additional receptor seems to enhance metabolic effects and fat loss in clinical trials. That's why people are excited about retatrutide, though it's still early, and we're waiting on larger studies to see exactly how it compares head-to-head with the others. And that's going to be key, since right now we don't have direct comparisons to other advanced therapies like semaglutide or tirzepatide in the published Phase 2 data. How does retatrutide compare to semaglutide and tirzepatide? Total body weight loss: Now let's put these three medications side by side and look at what the trials actually tell us about total body weight loss. Starting with retatrutide: in its Phase 2 obesity program, the numbers were unusually large, especially given the relatively short trial window. In the 48-week study, people on the higher doses—8 or 12 milligrams weekly—lost about 22 to 24% of their body weight on average. That's the result that really made headlines. It's worth noting that some trials report slightly different averages depending on the group studied—people with obesity but no diabetes versus people with type 2 diabetes—but across the board, that 48-week signal is consistently very strong. For comparison, let's step back to semaglutide at the 2.4 mg dose, which was tested in the pivotal STEP-1 trial. Over 68 weeks, participants lost about 15% of their body weight on average. That was a landmark finding when it was published in the New England Journal of Medicine—it essentially set the modern benchmark for what a GLP-1 monotherapy could do. Then we have tirzepatide, the dual GIP and GLP-1 agonist. The SURMOUNT-1 trial, which ran for 72 weeks, showed dose-dependent results: about 15% weight loss at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg, compared to only around 3% with placebo. Other obesity studies with tirzepatide have backed this up, especially at the higher doses. And in head-to-head comparisons with semaglutide, tirzepatide has consistently come out on top. So if we zoom out: retatrutide's Phase 2 data suggest the greatest average reductions—over 22%—in less than a year. Tirzepatide follows closely behind with around 21% over 72 weeks. And semaglutide shows very meaningful, but smaller, weight loss of around 15% over a similar time frame. The big caveat here is that these aren't perfect apples-to-apples comparisons. The trials differed in their length, the types of patients enrolled—some had type 2 diabetes, some did not—their baseline weights, and even the way results were reported. Plus, retatrutide is still in Phase 2 for obesity, whereas semaglutide and tirzepatide already have large Phase 3 programs and real-world data backing them up. Visceral fat reduction: Next, let's talk about visceral fat reduction—that's the deep fat that surrounds organs like the liver, pancreas, and intestines. It's particularly important because high levels of visceral fat are strongly linked to cardiometabolic disease. Starting with retatrutide, one of the Phase 2 substudies used DEXA scans to measure body composition in detail. At the higher doses—8 and 12 milligrams per week—participants saw visceral fat drop by about 29 to 31% over 48 weeks. That's a very large relative reduction in under a year and one of the reasons people are excited about retatrutide's potential not just for weight loss, but also for improving long-term metabolic health. How does that compare to the other drugs? With semaglutide, we also have DEXA and imaging substudies from the STEP program and follow-up mechanistic work. These consistently show meaningful visceral fat reductions, along with improvements in the ratio of lean to fat mass. The difference is that semaglutide studies typically report VAT changes as “significant and clinically relevant,” but they don't always publish one clear headline number that's directly comparable to retatrutide's ~30%. In other words, semaglutide definitely lowers visceral fat, but depending on the study and population, the exact percentage looks different. For tirzepatide, we also have imaging-based data from the SURMOUNT trials and related body-composition studies. These show that the majority of weight lost is fat mass—including a significant portion of visceral fat. Some analyses report reductions on par with what's seen with GLP-1 therapies, while others suggest tirzepatide may push a bit further. But again, the actual percentages vary depending on whether the study used DEXA, CT, or MRI, and on who was enrolled. The big caveat here is that we don't yet have a head-to-head imaging study comparing all three drugs in the same population with the same methods. Retatrutide's ~30% visceral fat drop is certainly eye-catching, but without that kind of standardized comparison, it's hard to say definitively whether it's truly better than semaglutide or tirzepatide. Lean muscle mass preservation: Now let's shift to lean mass preservation, which is just as important as total weight or fat loss. Across all of the modern obesity drug trials, one thing has been consistent: most of the weight people lose is fat, but some lean tissue is lost too. That's expected whenever you're in a sustained calorie deficit. The question is how much muscle is preserved, and how the proportions break down. With retatrutide, the DEXA substudy showed something reassuring. Even though people lost a lot of total weight and fat, the proportion of lean mass lost compared to total weight loss was similar to what we see with other therapies. In other words, the drug seems to drive large fat reductions without causing disproportionate muscle loss. Interestingly, the absolute amount of lean tissue lost in kilograms was pretty stable across different doses, even though fat loss varied quite a bit. That suggests the extra weight loss with higher doses is really coming from fat, not muscle. Looking at semaglutide, the STEP trials with DEXA scans reported the same general pattern. People lost more fat than lean mass, and when you adjust for the total weight loss, body composition actually improved. In fact, some analyses showed a slight increase in the percentage of body weight that was lean tissue, even though the absolute lean mass in kilograms went down. So again, it's not that muscle isn't affected—it is—but fat loss makes up the majority of the change. For tirzepatide, the SURMOUNT body-composition studies found that about 75% of the weight lost is fat and about 25% is lean mass. That split is very similar to what was seen in the placebo groups, which means the drug isn't shifting the balance unfavorably. It preferentially reduces fat, while lean mass preservation is in the same ballpark as semaglutide and retatrutide. Now, here's the important nuance: lean mass on a DEXA scan isn't just skeletal muscle. It includes water, organ tissue, and other components. So if someone loses 3 or 4 kilograms of “lean mass,” we don't know how much of that is functional muscle versus water or smaller organ size. That's why these numbers can be misleading if you take them at face value. And this is where lifestyle comes in. Resistance training and adequate protein intake are critical alongside medication. Lifting weights or doing bodyweight resistance work helps preserve functional muscle, while getting enough protein—typically somewhere in the range of 0.8 to 1 gram per pound per day depending on age and activity—supports muscle repair and maintenance. Every trial we've seen shows that the best outcomes, in terms of maintaining strength and function, come from pairing these drugs with exercise and nutrition strategies. That way, the unavoidable lean mass changes have far less impact on long-term metabolic health and performance. Limitations, biases, and what's missing (the critical context). No large, peer-reviewed head-to-head trials (yet) comparing retatrutide with semaglutide or tirzepatide for the same endpoints using identical imaging protocols. Most comparisons are cross-trial and therefore imperfect. Retatrutide Phase-2 was often compared to placebo or dulaglutide (in the T2D DEXA substudy) rather than to semaglutide or tirzepatide. A head-to-head (planned/registered) study vs tirzepatide is listed on ClinicalTrials.gov but results are not published yet. Different populations & durations. Some retatrutide data come from cohorts that include people with T2D or NAFLD; semaglutide STEP trials were often in people with obesity (without diabetes) and run longer (68 weeks), while tirzepatide SURMOUNT trials ran to 72 weeks. These differences change the absolute and percent outcomes. Funding and reporting bias. Many of the early retatrutide analyses are industry-funded (Eli Lilly), which is standard for drug development, but it requires us to carefully read methods, endpoints, and completeness of reporting. Independent replication and Phase-3 confirmation matter. Imaging method variation. VAT reported by DXA vs MRI vs CT are not directly interchangeable. Some trials report VAT area, others percent change; that complicates cross-trial percent comparisons.  Thanks for listening to The Peptide Podcast. If today's episode resonated, share it with a friend. Until next time, be well, and as always, have a happy, healthy week.

Discover why the dreaded fall turnover doesn't have to ruin your bass fishing season! Host breaks down the science behind lake turnover and reveals game-changing strategies using modern forward-facing sonar to target suspended bass when others are going home empty-handed. Learn to find oxygen-rich water, decode thermocline patterns, and master topwater techniques that turn the toughest fishing conditions into your biggest advantage.Become a supporter of this podcast: https://www.spreaker.com/podcast/bass-cast-radio--1838782/support.Become a Patreon memebet now for less then a pack of worms you can support Bass Cast Radio as well as get each epsiode a day early & commercial free. Just click the link below. PATREON 

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials.

Dr. Jack Jennings from Washington University in St. Louis discusses thermoprotection techniques for musculoskeletal ablation, highlighting strategies to safeguard vital structures during image-guided procedures. Drawing on nearly two decades of experience, he emphasizes both passive and active protective approaches that enhance safety and effectiveness in treating benign and malignant lesions. Thermal Protection Techniques for Image-guided Musculoskeletal Ablation. Thurlow et al. RadioGraphics 2025; 45(4):e240078.

Send us a textDr. Michael Koren joins Kevin Geddings to discuss the pivotal role imaging has played in diagnosis and understanding of various diseases. Dr. Koren notes that before the science of imaging, the only way to see what was going on inside the body was with a knife. They then discuss some of the newest applications of imaging and how the use of CT scans and amyloid PET scans can see inside the heart and arteries to see how a disease is progressing or the effectiveness of new medications.They talk about the progress that has been made and how we are able to see what's happening, but note that access to these imaging technologies is not evenly available and that sometimes cost or insurance can get in the way of healthcare access. Dr. Koren then points out that clinical research may offer some patients a way for some patients to access these imaging technologies outside of the traditional healthcare system if they have risks or signs of diseases being studied.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Brett Vanderzee preaches a sermon on Genesis 1:26-28; 2:7-9 in a series entitled "Beauty Will Save the World."

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Should MRI-guided interventions be on your radar? Find out why the future of interventional radiology might lie in MRI guidance with experts Dr. Clifford Weiss from Johns Hopkins University and Dr. David Woodrum from the Mayo Clinic.---This podcast is supported by:Medtronic Emprinthttps://www.medtronic.com/emprint---SYNPOSISThe physicians join host Dr. Chris Beck to explore the benefits of MRI guided procedures, including superior imaging capabilities and reduced radiation exposure. Dr. Weiss and Dr. Woodrum detail the challenges and barriers to adoption, like the intricate set up needed to protect equipment from a strong magnetic field. They highlight the significant technological advancements and collaborations between MRI and device companies that are set to make MRI guided interventions more accessible and practical for everyday use. They also discuss the reimbursement paradigm for MRI guided biopsies and how similar the algorithm is to CT guided procedures.The episode closes with unique insights for young physicians on training opportunities and the promising future of MRI guided interventions for trainees looking to bring a different approach to their future practices.---TIMESTAMPS00:00 - Introduction05:13 - The Advantages of MRI in Interventional Radiology13:44 - Technical Insights and Challenges of MRI Guided Procedures18:46 - Future Prospects and Industry Developments in MRI Guided Interventions31:01- Development of Hybrid MRI Rooms48:19 - Economic Considerations and Reimbursement52:33 - Community Support for MRI Interventions56:41 - Conclusion and Final Thoughts---RESOURCESInternational Society for Magnetic Resonance in Imaging:https://www.ismrm.org/

An inside scoop to pediatric radiology training and beyond. Amy Mehollin-Ray, MD, speaks with host Raisa Amiruddin, MBBS, on the many training pathways available and common misconceptions about the subspecialty. Academics, teleradiology, private or hybrid practice: the opportunities are everywhere! https://www.ajronline.org/doi/10.2214/AJR.25.33866

Dr. Lauren Kim speaks with Dr. Anna Rita Larici about the international consensus guidelines for imaging and managing post-COVID-19 residual lung abnormalities. They discuss the importance of standardized definitions, CT imaging protocols, and unified terminology to guide diagnosis and follow-up care for patients with long COVID. Best Practice: International Multisociety Consensus Statement forPost–COVID-19 Residual Abnormalities on Chest CT Scans. Yoon et al. Radiology 2025; 316(1):e243374.

When radiology meets surgery, endometriosis care becomes more precise, personalized, and proactive. In this BackTable OBGYN Brief, host Dr. Mark Hoffman is joined by Dr. Wendaline VanBuren, an associate professor of radiology at Mayo Clinic, and Dr. Tatnai Burnett, a minimally invasive GYN surgeon at Mayo Clinic, to discuss the complexities of diagnosing and managing endometriosis. The discussion covers the roles of advanced imaging techniques like MRI and ultrasound, the importance of pre-surgical planning, and the need for multidisciplinary collaboration. They share their approach to managing symptomatic and asymptomatic patients, the use of hormonal treatments, and the significance of monitoring potential malignant transformations in endometrioma cases. The episode underscores the critical role of imaging in planning effective surgical interventions for patients while highlighting the progression of endometriosis management protocols. TIMESTAMPS 00:00 - Introduction  01:07 - Discussing Endometriosis Management 02:18 - Imaging Techniques and Their Importance 04:24 - Interdisciplinary Collaboration 05:40 - Advanced Imaging Protocols 08:12 - Monitoring and Follow-Up Strategies 08:50 - Concerns About Malignancy 11:04 - Future Directions CHECK OUT THE FULL EPISODE OBGYN Ep. 69 https://www.backtable.com/shows/obgyn/podcasts/69/imaging-protocols-to-guide-endometriosis-treatment

Send us a textIn today's episode of PTs Snacks podcast, hosted by Kasey, we dive into the intricacies of high ankle sprains, also known as syndesmotic ankle sprains. We'll explore the relevant anatomy, common mechanisms of injury, diagnostic techniques, and treatment strategies. Kasey also highlights the importance of distinguishing high ankle sprains from other types of ankle injuries and discusses both non-surgical and surgical management approaches. Whether you're a seasoned physical therapist or a student, this episode is packed with valuable insights to enhance your clinical practice.00:00 Introduction to PTs Snacks Podcast00:19 Understanding High Ankle Sprains00:56 Anatomy Review: Syndesmotic Ligaments03:43 Mechanism of Injury05:29 Clinical Presentation and Diagnosis06:43 Stress Tests for High Ankle Sprains08:29 Imaging and Differential Diagnoses09:30 Treatment and Rehabilitation Stages11:43 Prognosis and Final Thoughts12:19 Special Offers and ConclusionGo to PT Final Exam using this link to access great studying options to conquer the NPTE!Support the showStay Connected! Make sure to hit follow now so you don't miss an episode! Got questions? Email me at ptsnackspodcast@gmail.com or leave feedback HERE. You can also join the email list HERE Need CEUs Fast?Time and resources short? Medbridge has you covered: Get over $100 off a subscription with code PTSNACKSPODCAST: Medbridge Students: Save $75 off a student subscription with code PTSNACKSPODCASTSTUDENT—a full year of unlimited access for less! Prepping for the NPTE? Get all the study tools you need to master it at PT Final Exam. Use code PTSnacks at checkout to get a discount! Want to Support the Show?Help me keep creating free content by: Sharing the podcast with someone who'd benefit. Contributing directly via the link...

A new study shows that more degenerative changes on cervical MRIs actually mean less severe headaches in patients with neck pain. So, if you or your patients are stressing over how bad their imaging looks, it's time to rethink that. The big takeaway? Imaging findings don't dictate the future—holistic care, communication, and proactive strategies make the real difference.Episode Notes: Association between cervical MRI findings and patient-reported severity of headache in patients with persistent neck painLeander Tables- Save $1,000 on the Series 950 Table using the code EBC2025 — their most advanced flexion-distraction tablePatient Pilot by The Smart Chiropractor is the fastest, easiest to generate weekly patient reactivations on autopilot…without spending any money on advertising. Click here to schedule a call with our team.Our members use research to GROW their practice. Are you interested in increasing your referrals? Discover the best chiropractic marketing you aren't currently using right here!

In this episode, Dr. Erica Lacher and show host Justin Long take a closer look at all the different imaging modalities available to veterinarians, and how they are used. Topics include digital radiograh (x-ray), ultrasound, CT scan, MRI, and PET scan. 

Precision matters in cardiology. Master late gadolinium enhancement techniques to accurately assess myocardial viability and guide treatment. Credit available for this activity expires: 9/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-imaging-cardiac-mri-late-gadolinium-enhanced-2025a1000nh4?ecd=bdc_podcast_libsyn_mscpedu

In this episode, we begin with a brief introduction of our podcasters, Tom DeSilvio, Brennan Flannery, Yash Singh, and Ghazal Zandieh, before welcoming Dr. Gary Luker, Editor‑in‑Chief of the RSNA journal, Radiology: Imaging Cancer. Our goal is to showcase and better introduce the journal while highlighting the future of individualized cancer imaging. Dr. Luker joins us to discuss how advanced imaging, artificial intelligence, and translational research are transforming personalized cancer care.

Dr. Linda Chu speaks with Dr. Andrew Trout, Professor of Radiology and Director of Clinical Research at Cincinnati Children's, and Dr. Erin Angel, Vice President of Research and Scientific Affairs at GE HealthCare. They discuss the unique challenges of pediatric imaging and how collaboration and technology are advancing care for young patients while improving imaging for all. Sponsored by GE HealthCare.

Dr. Shravan Sridhar explores the evidence-based approach to transthoracic needle biopsy, covering indications, performance metrics, complications, and risk mitigation strategies. Listeners will gain practical insights on patient selection, technical considerations, and navigating controversial scenarios to optimize outcomes in clinical practice. Evidence-based Approach to Transthoracic Needle Biopsy: Procedural Techniques, Risks, and Controversies. Sridhar et al. RadioGraphics 2025; 45(9):e240094.

The scripture this morning was Psalm 139:1-12. Rev. Laura Mayo gave the Proclamation.

As part of the 2025 Developmental Disabilities Conference, Dr. Elysa Marco talks about various biological approaches to therapy. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40623]

As part of the 2025 Developmental Disabilities Conference, Dr. Elysa Marco talks about various biological approaches to therapy. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40623]

As part of the 2025 Developmental Disabilities Conference, Dr. Elysa Marco talks about various biological approaches to therapy. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 40623]

In episode 485, Stacey Richter interviews Dr. Cristin Dickerson on the topic of direct contracting for imaging services. They discuss the high costs of imaging, which can account for 6-11% of a plan sponsor's healthcare spend. The episode covers the potential for significant cost savings and improved patient access through direct contracting, bypassing traditional TPAs that may have conflicts of interest or contractual constraints.  Dr. Dickerson, who is the founding partner of Green Imaging, explains how her organization has successfully implemented direct contracting, providing affordable and high-quality imaging services nationwide. They also address common barriers such as complexity in coding and payment processes, the reluctance of TPAs, and the habitual referral to 'down the hall' services. The conversation highlights the importance of price transparency, patient education, and how Green Imaging supports plan sponsors in navigating these challenges. === LINKS ===

Host: Darryl S. Chutka, M.D. Guests: Christopher Francois, M.D. The risk of thoracic aortic dissection increases as the diameter of the aorta widens. A diameter greater than 5 cm is associated with an increased risk of dissection in the general population. Patients with Marfan Syndrome have defective connective tissue and dissection commonly occurs with diameters less than 5 cm. Other health conditions associated with aortic dilation and potential dissection include Ehlers Danlos and those with bicuspid aortic valves.  It therefore becomes extremely important to accurately assess the aorta. Fortunately, we now have a variety of imaging tools available and several of these tools are relatively new. My guest for today's podcast is Dr. Christopher Francois, from the Department of Diagnostic Radiology at the Mayo Clinic and he'll bring us up to date regarding the most recent imaging techniques as we continue our series on vascular medicine. We'll discuss who's at risk for an aortic aneurysm, when some of the more traditional imaging is indicated and when we should consider some of the newer imaging tools. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Dizziness in the emergency department is common—and complicated. Today, hosts Dr. Abbie Ross, PT, NCS and Dr. Dani Tolman, PT talk with Dr. Peter Johns (MD) and Dr. Rebekah Griffith, PT about what actually works in the ED: using the HINTS exam correctly, avoiding unnecessary imaging and meclizine-only discharges, knowing when to call stroke, and why physical therapists in the ED can transform safety, outcomes, and costs.You'll hear about how to triage dizzy patients, spot posterior circulation stroke red flags, treat BPPV efficiently, and keep patients safe when answers aren't immediate. We also cover topics such as orthostatic hypotension, POTS, rapid-access dizzy clinics, and practical discharge planning.About the GuestsPeter Johns, MD — Emergency physician and vertigo educator (creator of “Spin Class” vertigo course and a popular YouTube channel).Dr. John's "Spine Class" Course: https://emneuro.com/spinclass/Dr. John's YouTube Channel: https://www.youtube.com/@PeterJohnsRebekah Griffith, PT, DPT — Emergency Department physical therapist and educator advocating for PT/OT presence in EDs nationwide.Dr. Griffith's Website: https://theeddpt.com/Instagram: https://www.instagram.com/theeddpt/https://www.instagram.com/theeddpt/Key TakeawaysUse HINTS to rule in peripheral vestibular dysfunctionBPPV is common and under-treated—confirm with positional nystagmus and treat with the correct maneuvers.Assess gait and orthostatics upright, not just vitals in bed; orthostatic hypotension is frequently missed.Embedding PTs in EDs improves safety, reduces unnecessary imaging and admissions, and boosts patient/provider satisfaction.Upstream PT access (outpatient/telehealth) prevents many ED visits and fear-avoidant patterns (e.g., PPPD risk).If this episode helped you, subscribe, like, and share. Comment with your biggest ED dizziness challenge—and we may just cover it in a future episode!#Dizziness #Vertigo #BPPV #HINTSExam #Stroke #EmergencyMedicine #VestibularRehab #PhysicalTherapy #POTS #OrthostaticHypotension #NeuroPT #TalkDizzyToMeHosted by:

Patient Selection and the Role of Echo Imaging for Tricuspid Structural Heart Procedures   Guest: Jeremy Thaden, M.D. Host: Paul Friedman, M.D.   This podcast will give an overview of the growth of transcatheter structural heart procedures in recent years and the co-evolution of structural heart imaging (echocardiography) for patient selection and guidance.   Topics Discussed: Mayo's experience with transcatheter structural heart procedures How has echo imaging evolved to facilitate guidance of structural heart procedures? What advice can you give for those interested in structural heart imaging?    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

HIFU (high-intensity focused ultrasound) is one of the most talked-about focal therapies in prostate cancer—but who is it really right for? In this conversation, Dr. Matthew Cooperberg (UCSF)—a leading voice in urology, epidemiology, and integrative prostate cancer care—breaks down patient selection vs. energy modality, how modern imaging (MRI, fusion, RSI) drives precision, what genomics (e.g., Decipher) can and can't tell us, and how salvage options compare after focal therapy vs. radiation. We also tackle lifestyle factors, trial design, and why midlife PSA screening (ideally

In this episode of Keeping Abreast, Dr. Jenn Simmons welcomes Dr. Hania Bednarski, a breast surgeon pioneering cryoablation as an alternative to conventional breast cancer surgery.For decades, breast cancer treatment has changed little—yet Dr. Bednarski is forging a new path, reducing trauma while preserving women's wholeness. She shares her journey from trauma and hand surgery into breast care, and ultimately into cryoablation. Together, she and Dr. Jenn explore why this approach matters, how it's performed, and what it means for the future of breast cancer care.The conversation challenges assumptions about mammograms, chemotherapy, lymph node surgery, and hormones. Both physicians stress the importance of autonomy, personalized treatment, and a future where patient choice—not rigid protocols—guides care.This episode is essential for women navigating breast health, practitioners curious about new frontiers, and anyone passionate about transforming medicine from invasive to empowering.In This Episode, You Will Learn:How Dr. Bednarski's career led her to cryoablationWhy conventional surgery can cause lasting traumaWhat cryoablation is, how it works, and who it helpsWhy informed consent and patient choice matterThe pitfalls of mammograms and over-diagnosisHow cryoablation may engage the immune systemWhy lymph node surgery is diagnostic—not curativeThe truth about estrogen and breast cancer riskHow financial incentives block innovation

Brain lesion extent, growth, and body composition in children with cerebral palsyStina Oftedal, Simona Fiori, Kristie L Bell, Katherine A Benfer, Leanne Sakzewski, Robert S Ware, Peter S W Davies, Roslyn N BoydPMID: 40745624DOI: 10.1111/dmcn.16427AbstractAim: To investigate the relationship between growth, body composition, and the extent of brain lesion measured using structural magnetic resonance imaging (MRI) in children with cerebral palsy (CP).Method: This prospective population-based cohort study recorded 359 assessments from 124 children with CP aged 18 months to 13 years (38% female, Gross Motor Function Classification System [GMFCS] levels I = 50, II = 24, III = 17, IV = 12, and V = 21). A neurologist assessed the extent of the brain lesion using a validated semi-quantitative scale (global, basal ganglia/brainstem, hemispheric and corpus callosum scores). Height (HTZ), weight (WTZ), and head circumference (HDZ) z-scores were calculated. The Fat Mass Index (FMI) and Fat-Free Mass Index (FFMI) were determined using a deuterium dilution technique, bioelectrical impedance or dual-energy X-ray absorptiometry, and height. Data were analysed using mixed-effects linear regression.Results: Greater global (β = -0.04, 95% confidence interval [CI] = -0.07 to -0.02), basal ganglia/brainstem (β = -0.06, 95% CI = -0.11 to -0.02), corpus callosum (β = -0.27, 95% CI = -0.27 to -0.12), and hemispheric (β = -0.08, 95% CI = -0.12 to -0.04) scores were associated with lower HTZ. Greater global (β = -0.03,95% CI = -0.06 to -0.01) and corpus callosum (β = -0.23, 95% CI = -0.40 to -0.06) scores were associated with lower WTZ. A greater hemispheric score (β = -0.06, 95% CI = -0.119 to -0.001) was associated with lower HDZ. Semi-quantitative MRI scores were not associated with FMI or FFMI.Interpretation: Greater extent of the brain lesion was significantly associated with lower HDZ, HTZ, and WTZ but not body composition in children with CP aged 18 months to 13 years.Keywords: Body composition; Brain imaging; Brain lesion; Cerebral palsy; Growth.

In this episode of the Nifty Thrifty Dentists Podcast, Dr. Glenn Vo sits down with Nathan Hudson of Renew Digital to break down one of the biggest myths in dentistry: why you don't have to buy brand new when it comes to CBCTs, digital pans, and scanners. Nathan shares how Renew Digital's certified refurbished process works, why it's safer than buying off a buddy or a dental garage sale group, and how dentists can save 30–60% without sacrificing quality, warranty, or support. They also cover: Why buying “cheap” can cost you more in the long run Regulatory issues most doctors forget when buying second-hand The upgrade and trade-in options Renew Digital offers Why startup practices and implant/restorative dentists benefit the most How Renew Digital helps you protect your time, money, and sanity

Dr. Vera Bittner, Section Head of General Cardiology, Prevention, and Imaging and Medical Director of the Coronary Care Unit at UAB, discusses the risks associated with elevated triglycerides and how to combat this potentially dangerous condition.About the TeamDr. Alain Bouchard is a clinical cardiologist at Cardiology Specialists of Birmingham, AL. He is a native of Quebec, Canada and trained in Internal Medicine at McGill University in Montreal. He continued as a Research Fellow at the Montreal Heart Institute. He did a clinical cardiology fellowship at the University of California in San Francisco. He joined the faculty at the University of Alabama Birmingham from 1986 to 1990. He worked at CardiologyPC and Baptist Medical Center at Princeton from 1990-2019. He is now part of the Cardiology Specialists of Birmingham at UAB Medicine.Dr. Philip Johnson is originally from Selma, AL. Philip began his studies at Vanderbilt University in Nashville, TN, where he double majored in Biomedical and Electrical Engineering. After a year in the “real world” working for his father as a machine design engineer, he went to graduate school at UAB in Birmingham, AL, where he completed a Masters and PhD in Biomedical Engineering before becoming a research assistant professor in Biomedical Engineering. After a short stint in academics, he continued his education at UAB in Medical School, Internal Medicine Residency, and is currently a cardiology fellow in training with a special interest in cardiac electrophysiology.Medical DisclaimerThe contents of the MyHeart.net podcast, including as textual content, graphical content, images, and any other content contained in the Podcast (“Content”) are purely for informational purposes. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on the Podcast!If you think you may have a medical emergency, call your doctor or 911 immediately. MyHeart.net does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Podcast. Reliance on any information provided by MyHeart.net, MyHeart.net employees, others appearing on the Podcast at the invitation of MyHeart.net, or other visitors to the Podcast is solely at your own risk.The Podcast and the Content are provided on an “as is” basis.

A small imaging center uncovered hidden waste in patient access when scheduling workflows didn't match their tech stack. By streamlining tools, cutting manual steps, and aligning technology with real staff processes, they saved FTE hours, improved throughput, and reduced bottlenecks that drive revenue loss in imaging centers across the U.S.

What piques your clinical suspicion for biliary structure? And when is interventional endoscopy the preferred approach? Fine tune your diagnostic and treatment algorithm with Dr. Premal Trivedi from the University of Colorado and host Dr. Christopher Beck as they go in-depth on the management of biliary strictures.---This podcast is supported by:RADPAD® Radiation Protectionhttps://www.radpad.com/---SYNPOSISThe doctors first break down the signs and clinical picture that alert them to a possible biliary stricture. Dr. Trivedi then explains the steps of his workup and preferred imaging, and also describes his threshold to pursue percutaneous transhepatic cholangiography (PTC), especially in diffuse conditions like primary sclerosing cholangitis. Dr. Trivedi also walks through his procedural steps for PTC and drain placement, covering his best practices and typical intraoperative decision making.Dr. Trivedi then explains the role of angioplasty over the course of longitudinal treatment, balloon choice, and his upper limit of catheter upsizing. The doctors also delve into the role of interventional endoscopy and tackling complications such as bleeding and tube leakage. The conversation offers valuable insights for trainees and practitioners alike, and highlights future advancements in biliary interventions.---TIMESTAMPS00:00 - Introduction06:19 - Approach to Biliary Strictures08:10 - Workup and Imaging for Biliary Strictures20:41 - Accessing the Biliary System27:14 - Crossing the Obstruction: Next Steps33:22 - Endoscopic Evaluation and Its Role47:14 - Complications and Pain Management53:40 - Future of Biliary Management54:55 - Conclusion and Final Thoughts

Drs. Sophia O'Brien Austin Pantel, explore the role of 18F-Fluoroestradiol (FES) PET-CT in the diagnosis and management of ER-positive breast cancer. They review key findings from their RadioGraphics article, discuss updates to national guidelines, and highlight how FES imaging improves patient care by assessing estrogen receptor expression across all sites of disease. 18F-Fluoroestradiol: Current Applications and Future Directions. O'Brien et al. RadioGraphics 2023; 43(3):e220143

Episode 310 hosts Dr Jimmy Wang (Cosmetic Physician from Brisbane, Australia) In our ‘Masterclass Series' we host global experts to teach us about fillers, bio-stimulators, bio-remodellers, polynucleotides, exosomes and other products. (For toxin insights, check out our other mini-series, ‘The Tox Talks') In Chapter 8 we discuss BYRYZN Opuluxe V, a new topical skin booster product distributed by Hugel Aesthetics. We go through the science and inclusion of eight bioactive ingredients, the practical aspects of how to apply Byryzn, on-label and off-label uses, contraindications, patient selection, and some suggested marketing strategies.  00:00 Introduction  02:16 Introducing Dr. Jimmy Wang 02:37 Dr. Wang's Journey into Cosmetic Medicine 04:09 Differences in Clientele and Treatment Approaches 07:28 Exploring the BYRYZN Opuluxe V Product 11:09 Ingredients and Benefits of BYRYZN Opuluxe V 26:58 Application Methods and Clinical Protocols 29:56 Regulatory Questions and Off-Label Use 30:56 Patient Feedback and Clinical Observations 31:56 Objective Measurement and Imaging 36:28 Combination Treatments and Techniques 38:22 Contraindications and Adverse Reactions 42:29 Commercial Considerations and Pricing 47:09 Marketing and Compliance 49:37 Future of Regenerative Aesthetics 57:13 Final Thoughts and Tips     CHECK OUT OUR PATREON & GET A 7 DAY FREE TRIAL! BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST CONTACT US

Dr. Liew  shares her personal journey to becoming a rheumatologist inspired by a friend's diagnosis. She then discusses the condition in detail, addressing common misconceptions such as it being exclusive to white men and always showing up on imaging. Listeners will gain invaluable insights into the challenges of diagnosing this condition, social determinants affecting diagnosis, and reliable resources for further information. This episode is a must-listen for anyone navigating the labyrinth of rheumatic diseases, providing hope and knowledge to help you thrive.Episode at a glance:00:00 Introduction to Rheumer Has It Podcast00:26 Meet Dr. Jean Liew: Expert on Axial Spondyloarthritis00:40 Understanding Axial Spondyloarthritis01:41 Dr. Liew's Journey into Rheumatology04:16 Busting Myths: Axial Spondyloarthritis and Demographics (it's not just men!)06:50 Challenges in Diagnosing Axial Spondyloarthritis10:27 The Role of HLAB 27 in Axial Spondyloarthritis12:26 Imaging and Axial Spondyloarthritis14:38 Final Thoughts and ResourcesMedical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! 

Join Premium! Ready for an ad-free meditation experience? Join Premium now and get every episode from ALL of our podcasts completely ad-free now! Just a few clicks makes it easy for you to listen on your favorite podcast player.  Become a PREMIUM member today by going to --> https://WomensMeditationNetwork.com/premium So find your breath, And follow its rhythm within you. PAUSE… Breathing in, Breathing out.  Riding the motion of its waves, And letting it calm you down, Slow you down, And bring you here.  PAUSE… As thoughts enter your mind, See if you can invite them to pass along, Imaging them as clouds above you, Passing by in the beautiful blue sky. Join our Premium Sleep for Women Channel on Apple Podcasts and get ALL 5 of our Sleep podcasts completely ad-free! Join Premium now on Apple here --> https://bit.ly/sleepforwomen Join our Premium Meditation for Kids Channel on Apple Podcasts and get ALL 5 of our Kids podcasts completely ad-free! Join Premium now on Apple here → https://bit.ly/meditationforkidsapple I'm so glad you're taking the time to be with us today. My team and I are dedicated to making sure you have all the meditations you need throughout all the seasons of your life.  If there's a meditation you desire, but can't find, email us at hello@womensmeditationnetwork.com to make a request. We'd love to create what you want!  Namaste, Beautiful,